Display Settings:

Format

Send to:

Choose Destination
Front Pharmacol. 2012 May 3;3:82. doi: 10.3389/fphar.2012.00082. eCollection 2012.

SIRT2 as a Therapeutic Target for Age-Related Disorders.

Author information

  • 1Cell and Molecular Neuroscience Unit, Instituto de Medicina Molecular Lisboa, Portugal.

Abstract

Sirtuin proteins are conserved regulators of aging that have recently emerged as important modifiers of several diseases which commonly occur later in life such as cancer, diabetes, cardiovascular, and neurodegenerative diseases. In mammals, there are seven sirtuins (SIRT1-7), which display diversity in subcellular localization and function. SIRT1 has received much of attention due to its possible impact on longevity, while important biological and therapeutic roles of other sirtuins have been underestimated and just recently recognized. Here we focus on SIRT2, a member of the sirtuin family, and discuss its role in cellular and tissue-specific functions. This review summarizes the main scientific advances on SIRT2 protein biology and explores its potential as a therapeutic target for treatment of age-related disorders.

KEYWORDS:

SIRT2; aging; cancer; metabolic syndrome; neurodegenerative disorder

PMID:
22563317
[PubMed]
PMCID:
PMC3342661
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Frontiers Media SA Icon for PubMed Central
    Loading ...
    Write to the Help Desk